Pelvic inflammatory disease (PID) is a polymicrobial infection of the upper female genital tract: the cervix, uterus, fallopian tubes, and ovaries; abscess may occur. PID may be caused by sexually transmitted infections. Common symptoms and signs include lower abdominal pain, irregular vaginal bleeding, cervical discharge, and cervical motion tenderness. Long-term complications may include infertility, chronic pelvic pain, and ectopic pregnancy. Diagnosis includes polymerase chain reaction testing of cervical specimens for Neisseria gonorrhoeae and chlamydiae, microscopic examination of cervical discharge (usually), and ultrasonography or laparoscopy (occasionally). Treatment is with antibiotics.
Pelvic inflammatory disease (PID) may involve the cervix, uterus, fallopian tubes, and/or ovaries. Infection of the cervix (cervicitis) causes mucopurulent discharge. Infection of the fallopian tubes (salpingitis) and uterus (endometritis) tend to occur together. If severe, infection can spread to the ovaries (oophoritis) and then the peritoneum (peritonitis). Salpingitis with endometritis and oophoritis, with or without peritonitis, is often called salpingitis even though other structures are involved. Pus may collect in the tubes (pyosalpinx), and an abscess may form (tubo-ovarian abscess).
Etiology of PID
PID results from microorganisms ascending from the vagina and cervix into the uterus and fallopian tubes. The sexually transmitted infections Neisseria gonorrhoeae and Chlamydia trachomatis are common causes of PID. Mycoplasma genitalium, which is also sexually transmitted, can also cause or contribute to PID. Incidence of sexually transmitted PID is decreasing; < 50% of patients with acute PID test positive for gonorrhea or chlamydia.
PID usually also involves other aerobic and anaerobic bacteria, including pathogens that are associated with bacterial vaginosis. Vaginal microorganisms such as Haemophilus influenzae, Streptococcus agalactiae, and enteric gram-negative bacilli can be involved in PID, as can Ureaplasma species. Vaginal inflammation and bacterial vaginosis help in the ascending spread of vaginal microorganisms.
Фактори ризику
Pelvic inflammatory disease commonly occurs in women < 35 years old. It is rare before menarche, after menopause, and during pregnancy.
Risk factors include
Previous PID
Presence of bacterial vaginosis or a sexually transmitted infection
Other risk factors, particularly for gonorrheal or chlamydial infection, include
Younger age
Nonwhite race
Low socioeconomic status
Multiple or new sex partners or a male partner who does not use a condom
Douching
Symptoms and Signs of PID
Pelvic inflammatory disease commonly causes lower abdominal pain, fever, cervical discharge, and abnormal uterine bleeding, particularly during or after menses.
Цервіцит
In cervicitis, the cervix is erythematous and friable (bleeds easily). Mucopurulent discharge is common; usually, it is yellow-green and can be seen exuding from the endocervical canal.
Гострий сальпінгіт
Lower abdominal pain is usually present and bilateral but may be unilateral, even when both tubes are involved. Pain may also occur in the upper abdomen. Nausea and vomiting are common when pain is severe. Irregular bleeding (caused by endometritis) and/or fever each occur in up to one third of patients.
Occasionally, dyspareunia or dysuria occurs.
Even women with inflammation that is severe enough to cause scarring have minimal or no symptoms.
In the early stages, signs may be mild or absent. Later, cervical motion tenderness, guarding, and rebound tenderness are common.
PID due to N. gonorrhoeae is usually more acute and causes more severe symptoms than that due to C. trachomatis, which can be indolent. PID due to M. genitalium, like that due to C. trachomatis, is also mild and should be considered in women who do not respond to first-line therapy for PID.
Ускладнення
Fitz-Hugh-Curtis syndrome (perihepatitis that causes upper right quadrant pain) may result from acute gonococcal or chlamydial salpingitis. Infection may become chronic, characterized by intermittent exacerbations and remissions.
A tubo-ovarian abscess (collection of pus in the adnexa) develops in about 15% of women with salpingitis. It can accompany acute or chronic infection and is more likely if treatment is late or incomplete. Pain, fever, and peritoneal signs are usually present and may be severe. An adnexal mass may be palpable, although extreme tenderness may limit the examination. The abscess may rupture, causing progressively severe symptoms and possibly septic shock.
Hydrosalpinx is fimbrial obstruction and tubal distention with nonpurulent fluid; it is usually asymptomatic but can cause pelvic pressure, chronic pelvic pain, dyspareunia, and/or infertility.
Salpingitis may cause tubal scarring and adhesions, which commonly result in chronic pelvic pain, infertility, and increased risk of ectopic pregnancy.
Diagnosis of PID
High index of suspicion
Pelvic examination
Cervical tests for N. gonorrhoeae and C. trachomatis
Index of suspicion should be high, particularly in reproductive-age women and girls with risk factors, because clinical presentation is variable and even minimally symptomatic infection may have severe sequelae.
PID is suspected when women of reproductive age have lower abdominal pain or cervical or unexplained vaginal discharge, particularly with fever. PID is also considered when irregular vaginal bleeding, dyspareunia, or dysuria is unexplained.
A presumptive diagnosis of PID should be made and treatment initiated for sexually active young women and other women at risk for STIs if they are experiencing pelvic or lower abdominal pain, no cause for the illness other than PID can be identified, and if 1 or more of the following 3 minimum clinical criteria are present on pelvic examination:
Cervical motion tenderness
Uterine tenderness
Adnexal tenderness
In addition, on pelvic examination, a palpable adnexal mass suggests tubo-ovarian abscess.
If PID is suspected, NAAT (nucleic acid amplification test) of cervical specimens for N. gonorrhoeae and C. trachomatis (which is about 99% sensitive and specific) is done. If NAAT is unavailable, cultures are done. However, upper tract infection is possible even if tests for cervical infection are negative.
The white blood cell count may be elevated but is not helpful diagnostically. A pregnancy test should be performed in reproductive-age women.
If a patient cannot be adequately examined because of tenderness, imaging studies are done as soon as possible. Ultrasonography is the preferred first-line test. If ultrasound is not available or is inconclusive, other imaging modalities like CT scan may be performed to evaluate for abscess formation, including tubo-ovarian abscess.
Other indications for imaging are if an adnexal or pelvic mass is suspected clinically or if patients do not respond to antibiotics within 48 to 72 hours. In such cases, ultrasonography or CT scan is done as soon as possible to exclude tubo-ovarian abscess, pyosalpinx, and disorders unrelated to PID (eg, ectopic pregnancy, adnexal torsion).
If the diagnosis is uncertain after ultrasonography or other imaging modalities, or if empiric treatment for PID fails, laparoscopy should be done; purulent peritoneal material noted during laparoscopy is the diagnostic gold standard.
Цінні поради та підводні камені
|
Диференційний діагноз
If a pregnancy test is positive, ectopic pregnancy, which can produce similar findings, should be considered.
Other common causes of pelvic pain include endometriosis, adnexal torsion, ovarian cyst rupture, and appendicitis. Differentiating features of these disorders are discussed elsewhere in The Manual.
Fitz-Hugh-Curtis syndrome may mimic acute cholecystitis but can usually be differentiated by evidence of salpingitis during pelvic examination or, if necessary, with ultrasonography.
Treatment of PID
Antibiotics to cover N. gonorrhoeae, C. trachomatis, and organisms in the vaginal floras
When a PID diagnosis is suspected but cervical infection has not been confirmed or the patient does not meet all clinical criteria, empiric treatment of PID is given for several reasons:
Test results may take a few days.
Diagnosis based on clinical criteria can be inaccurate.
Not treating minimally symptomatic PID can result in serious complications.
Antibiotics are given empirically to cover N. gonorrhoeae, C. trachomatis, and vaginal flora, including anaerobes, and are modified based on laboratory test results.
Цінні поради та підводні камені
|
Patients with cervicitis or clinically mild to moderate PID do not require hospitalization. Outpatient treatment regimens (see table Regimens for Treatment of Pelvic Inflammatory Disease) usually also aim to eradicate bacterial vaginosis, which often coexists.
Sex partners of patients with N. gonorrhoeae or C. trachomatis infection should be treated.
Схеми лікування запальних захворювань органів малого тазу*
Treatment | Recommended Regimens | Alternative Regimens |
|---|---|---|
Parenteral† | Regimen A: Ceftriaxone 1 g IV every 24 hours PLUS Doxycycline 100 mg orally or IV every 12 hours PLUS Metronidazole 500 mg orally or IV every 12 hours Regimen B: Cefotetan 2 g IV every 12 hours OR Cefoxitin 2 g IV every 6 hours PLUS Doxycycline 100 mg orally or IV every 12 hours | Regimen C: Ampicillin/sulbactam 3 g IV every 6 hours PLUS Doxycycline 100 mg orally or IV every 12 hours Regimen D: Clindamycin 900 mg IV every 8 hours PLUS Gentamicin 2 mg/kg IV or IM (loading dose), followed by 1.5 mg/kg every 8 hours (maintenance dose); can be substituted with single daily dosing (3–5 mg/kg once a day) |
Oral or IM† | Regimen A: Ceftriaxone 500 mg IM in a single dose‡ PLUS Doxycycline 100 mg orally twice a day for 14 days WITH Metronidazole 500 mg orally twice a day for 14 days Regimen B: Cefoxitin 2 g IM in a single dose with probenecid 1 g orally administered concurrently in a single dose PLUS Doxycycline 100 mg orally twice a day for 14 days WITH Metronidazole 500 mg orally twice a day for 14 days Regimen C: Other parenteral 3rd-generation cephalosporin (eg, ceftizoxime, cefotaxime) PLUS Doxycycline 100 mg orally twice a day for 14 days WITH Metronidazole 500 mg orally twice a day for 14 days | Regimen D§: Levofloxacin 500 mg orally once a day for 14 days OR Moxifloxacin 400 mg orally once a day for 14 days WITH Metronidazole 500 mg orally twice a day for 14 days Regimen E: Azithromycin 500 mg IV once a day in 1 or 2 doses, followed by 250 mg orally once a day for a total duration of 7 days WITH OR WITHOUT Metronidazole 500 mg orally twice a day for 12 to 14 days |
* Recommendations are from the Centers for Disease Control and Prevention. Workowski KA, Bachmann LH, Chan PA, et al: Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 70(4):1-187, 2021 doi:10.15585/mmwr.rr7004a1 | ||
† Intramuscular or oral therapy can be considered for mild to moderate acute PID because the clinical outcomes with intramuscular/oral and parenteral therapy are similar. If patients do not respond to oral therapy within 72 hours, they should be reevaluated to confirm the diagnosis, and intravenous therapy should be given. | ||
‡ If patient weighs > 150 kg with documented gonococcal infection, 1 g of ceftriaxone should be administered. | ||
§ This regimen may be considered if the patient has a cephalosporin allergy, if community prevalence and individual risk of gonorrhea are low, and if follow-up is likely. Tests for gonorrhea must be done before therapy is started, and the following management is recommended:
| ||
If patients do not improve after treatment that covers the usual pathogens, PID due to M. genitalium should be considered. Patients may be treated empirically with moxifloxacin 400 mg orally once a day for 7 to 14 days (eg, for 10 days).
Women with PID are usually hospitalized if any of the following are present:
Uncertain diagnosis, with inability to exclude a disorder requiring surgical treatment (eg, appendicitis)
Pregnancy
Severe symptoms or high fever
Tubo-ovarian abscess
Inability to tolerate or follow outpatient therapy (eg, due to vomiting)
Lack of response to outpatient (oral) treatment
In these cases, IV antibiotics (see table Regimens for Treatment of Pelvic Inflammatory Disease) are started as soon as cultures are obtained and are continued until patients have been afebrile for 24 hours.
Tubo-ovarian abscess may require more prolonged IV antibiotic treatment. Treatment with ultrasound- or CT-guided percutaneous or transvaginal drainage can be considered if response to antibiotics alone is incomplete (1). Laparoscopy or laparotomy is sometimes required for drainage. Suspicion of a ruptured tubo-ovarian abscess requires immediate laparotomy. In women of reproductive age, surgery should aim to preserve the pelvic organs (with the hope of preserving fertility).
Довідковий матеріал щодо лікування
1. Goje O, Markwei M, Kollikonda S, et al: Outcomes of minimally invasive management of tubo-ovarian abscess: A systematic review. J Minim Invasive Gynecol 28 (3):556–564, 2021. doi: 10.1016/j.jmig.2020.09.014
Ключові моменти
The sexually transmitted pathogens Neisseria gonorrhoeae and Chlamydia trachomatis are common causes of PID, but infection is often polymicrobial.
PID can cause tubal scarring and adhesions, which commonly result in chronic pelvic pain, infertility, and increased risk of ectopic pregnancy.
Because even minimally symptomatic infection may have severe sequelae, index of suspicion should be high.
PCR and cultures are accurate tests; however, if results are not available at the point of care, empiric treatment is usually recommended.
Hospitalize women with PID based on clinical criteria (see above).
